Clearwater Cardiovascular Consultants

What Clearwater Cardiovascular Consultants does

Clearwater Cardiovascular Consultants (CCC) is a private, physician-owned and physician-led cardiovascular practice founded in 1975 and headquartered in Clearwater, Florida. The practice serves adult cardiac patients across Pinellas County and the greater Tampa Bay area through three office locations (Clearwater, Safety Harbor/Countryside, and Largo/Bardmoor) and an affiliated, wholly-owned ambulatory surgery center, Cardiovascular ASC, LLC. With 20+ board-certified cardiologists spanning interventional cardiology, electrophysiology, clinical cardiology, advanced imaging, and cardio-oncology plus advanced practice providers, CCC delivers a full spectrum of cardiovascular care: prevention and diagnostics, structural and coronary interventions, electrophysiology, device implantation, peripheral vascular work, and cardiac rehabilitation.

The product surface is built on a broad diagnostic and interventional service catalog rather than software. Diagnostics include echocardiography (with 3D TEE), cardiac CT/CCTA, nuclear cardiology (PET and SPECT), stress testing, and an FDA-cleared, third-party AI imaging layer (Cleerly) for 3D coronary plaque quantification — positioned as the first such deployment in Pinellas County as of November 2025. Procedural offerings span cardiac catheterization, complex/high-risk PCI, TAVR, MitraClip, WATCHMAN, ASD/PFO closure, catheter ablation (RF and cryo), and pacemaker/ICD/loop-recorder implantation. The practice also operates a dedicated Clinical Research Department (since 1992) running FDA-regulated sponsored studies, and a virtual cardiac rehab service delivered via a partnership with Recora.

The business model is fee-for-service professional and facility revenue derived primarily from third-party payer reimbursement (Medicare, Medicare Advantage, Medicaid, commercial insurance) plus patient cost-share, with three distinct streams: clinical cardiovascular services, ambulatory surgery center procedures, and sponsor-funded clinical research. Go-to-market is referral-driven (primary care and specialist referrals, hospital partnerships with Morton Plant, Mease Countryside, and the broader BayCare system) supplemented by direct patient self-scheduling and reputation-based channels. Disclosed cost-share signals indicate Medicare patients pay ~20% of allowable, commercial patients ~55% of day's charges, billed per visit; specific pricing is not publicly disclosed.

Name

Clearwater Cardiovascular Consultants

Legal name

Clearwater Cardiovascular Consultants

Website

https://cccheart.com

Company type

Private

Founded year

1975

Operating status

Operating

Headcount range

101–250 employees

Short description

A private, physician-owned cardiovascular practice founded in 1975, serving adult cardiac patients across Tampa Bay/Pinellas County through three offices and an affiliated ambulatory surgery center, spanning diagnostics, interventional cardiology, electrophysiology, and clinical research.

Ownership category

akta.pro rank

Product category

Cardiovascular Healthcare Services

NAICS

Offices of Physicians (62111), Diagnostic Imaging Centers (621512), Ambulatory Health Care Services (621)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Ambulatory Cardiology Diagnostic & Procedure Centers (Non-hospital-based) (HLAFABAK)

akta.pro secondary industries

Interventional Cardiology (PCI/Structural Heart) (HLAKABAB), General Cardiology (Consultative) (HLAKABAA), Cardiovascular / Cath Lab & Electrophysiology Centers (HLAFAIAI), Cardiac Diagnostic Centers (Echo/Stress Testing/Holter) (HLAFAKAE)

Keywords

• Cardiovascular care services
• Interventional cardiology
• Cardiac diagnostic imaging
• Electrophysiology services
• Structural heart procedures

Headquarters

HQ city

Clearwater

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Clinical Cardiovascular Services: Clearwater Cardiovascular Consultants generates revenue through providing comprehensive cardiovascular diagnostic and treatment services including office consultations, diagnostic testing (ECG, echocardiography, stress testing, cardiac CT, nuclear imaging), interventional procedures (cardiac catheterization, pacemaker implantation, ablation procedures), and ongoing cardiac care management. Revenue is derived from insurance reimbursements (Medicare, Medicaid, commercial insurance) and patient payments.
2. Ambulatory Surgery Center Procedures: Through their affiliated Cardiovascular ASC, the practice provides outpatient cardiac procedures including pacemaker/ICD implantation, diagnostic cardiac catheterization, and percutaneous coronary intervention (PCI) in a cost-effective ambulatory setting.
3. Clinical Research Studies: The practice conducts FDA-regulated investigational medical studies sponsored by pharmaceutical companies, device companies, government, and educational institutions, providing access to investigational treatments for patients while generating research-related revenue.

Pricing tiers

Go-to-market motion1 record

Distribution channels6 records

Marketing channels5 records

Core offering

Clearwater Cardiovascular Consultants is a private physician-owned cardiovascular practice delivering comprehensive outpatient and ambulatory cardiovascular services across diagnostics, interventional procedures, electrophysiology, structural heart therapies, and clinical research. The practice operates three office locations in Pinellas County plus an affiliated ambulatory surgery center, providing care ranging from routine ECG and stress testing to TAVR, MitraClip, WATCHMAN implantation, and AI-powered coronary plaque analysis.

Product overview

Clearwater Cardiovascular Consultants (CCC) is a private cardiovascular practice founded in 1975 offering comprehensive cardiovascular care across diagnostics, interventional procedures, electrophysiology, cardiac rehabilitation, and clinical research. The practice operates three office locations and an affiliated Cardiovascular ASC for outpatient procedures. Key services include AI-Powered Cleerly Heart Analysis (FDA-cleared AI imaging for 3D coronary artery analysis), Heart Rhythm Diagnosis and Treatment (including catheter ablation), Transcatheter Aortic Valve Replacement (TAVR) and MitraClip for structural heart disease, WATCHMAN device for stroke prevention, and Virtual Cardiac Rehab through a partnership with Recora. The practice also offers extensive diagnostic imaging (echocardiography, cardiac CT, PET/SPECT stress testing), cardiac catheterization, peripheral vascular services, an AFib Urgent Access Clinic, and FDA-regulated clinical research studies since 1992.

Differentiator

Problem solved

Functional benefit

Products and services

• AI-Powered Cleerly Heart Analysis FDA-cleared AI-powered heart imaging using coronary CT angiography (CCTA) to generate 3D analysis of heart arteries, measuring both calcified and soft plaque to detect early signs of coronary artery disease before symptoms appear.
• Heart Rhythm Diagnosis and Treatment Comprehensive arrhythmia care including electrophysiology studies (EPS), Holter and event monitors, implantable loop recorders, tilt-table testing, catheter ablation (radiofrequency and cryoablation), pacemaker and ICD implantation, and cardioversion.
• Transcatheter Aortic Valve Replacement (TAVR) Minimally invasive catheter-based delivery of a collapsed aortic valve through the groin or shoulder to replace a diseased aortic valve without conventional open-heart surgery, enabling same-day walking and next-day discharge for most patients.
• Transcatheter Mitral Valve Repair (MitraClip) Catheter-based mitral valve repair using small clips delivered via a groin puncture to treat mitral regurgitation without open-heart surgery.
• WATCHMAN Device Implantation Percutaneous implantation of a left atrial appendage (LAA) closure device to reduce stroke risk in atrial fibrillation patients who cannot take anticoagulants.
• Virtual Cardiac Rehab with Recora Virtual cardiac rehabilitation service delivered through the Recora digital health platform, offering personalized heart health programs, supervised exercise, and educational tools for post-procedure recovery from home.
• Atrial Septal Defect / Patent Foramen Ovale Repair Transcatheter closure of atrial septal defects and patent foramen ovale using collapsible disc devices delivered via catheter through a small groin puncture.
• AFib Urgent Access Clinic Specialty clinic providing expedited appointments within 48 hours for new-onset or previously diagnosed atrial fibrillation patients, offering rapid access to electrophysiology specialists and comprehensive evaluation and treatment strategies.
• Cardiac Catheterization Catheter-based diagnostic and interventional procedures allowing physicians to perform angiography and treatments by threading a catheter through a blood vessel to the heart.
• Echocardiography Heart ultrasound imaging including transthoracic, transesophageal (TEE) with 3D imaging, and stress echocardiography to evaluate heart structure, function, and valve disease.
• Cardiovascular Computed Tomography Noninvasive cardiac CT imaging including coronary CT angiography, calcium scoring, and vascular CT angiography for carotid, abdominal aorta, pulmonary, renal, and thoracic aorta assessment.
• Cardiac PET Stress Testing Nuclear heart scan using a safe radioactive tracer injected into the bloodstream to create pictures of the heart for evaluating heart health and blood flow.
• Cardiac SPECT Stress Testing Nuclear imaging test using a radioactive substance and nuclear camera to capture pictures of blood flow to the heart at rest and after stress to detect reduced blood flow or heart damage.
• ECG (Electrocardiogram) Standard test detecting and recording the electrical activity of the heart to identify and locate heart problems, displaying heart rate, rhythm, and electrical signal timing.
• Complex Coronary Interventions Advanced interventional treatment of complex coronary artery disease including high-risk PCI, atherectomy for heavy calcification, bifurcation stenting, chronic total occlusion (CTO) recanalization, and mechanical circulatory support procedures.
• Implantable Cardioverter Defibrillators (ICD) Implantation of a small device in the chest or abdomen that uses electrical pulses or shocks to control life-threatening irregular heartbeats and prevent sudden cardiac arrest.
• Pacemaker Implantation Implantation of a small device under the skin of the chest or abdomen that uses electrical pulses to prompt normal heart rate, available in single, dual, biventricular, and leadless configurations.
• Implantable Loop Recorder Insertion of a small heart-monitoring device beneath the chest skin that records heart rhythm continuously for up to three years to detect infrequent arrhythmias or fainting spells.
• Peripheral Angiography & Intervention Diagnosis and treatment of peripheral artery disease (PAD) using angiography and interventions including peripheral balloon angioplasty, stent placement, and rotational atherectomy.
• Peripheral Vascular Studies Diagnostic testing of blood flow through peripheral arteries and veins to diagnose PAD, including PVR studies, ABI studies, exercise testing, vascular ultrasound, Doppler ultrasound, duplex ultrasound, and peripheral vascular angiography.
• Stress Echocardiography Combined echocardiography and stress test (exercise or medication-induced) to evaluate heart function at rest and under stress for diagnosing coronary artery disease and assessing pumping function and valve status.
• Stress Testing Heart stress test evaluating heart function during physical activity by monitoring heart rate, blood pressure, and electrocardiograms while exercising on a treadmill or bicycle, or using medication to simulate exercise.
• Transesophageal Echocardiography (TEE) with 3D Imaging Specialized echocardiogram using a transducer advanced down the esophagus to provide high-resolution 2D and 3D images for assessing valve dysfunction, cardioversion evaluation, and congenital heart disease.
• Carotid Ultrasound Ultrasound imaging of the carotid arteries to detect carotid artery disease and stroke risk by measuring plaque buildup in the arteries supplying oxygen-rich blood to the brain.
• Coronary Calcium Scan CT scan of the heart that detects and measures calcium-containing plaque in the coronary arteries to identify potential coronary artery disease before symptoms appear.
• Venous Ablation for Varicose Veins and Venous Ulcers Endovenous laser or radiofrequency ablation for varicose veins and venous ulcers caused by chronic venous insufficiency, using heat and/or chemicals delivered via catheter to close diseased veins.
• Cardiovascular ASC (Ambulatory Surgery Center) Affiliated ambulatory surgery center providing outpatient cardiovascular procedures including pacemaker and ICD implantation, implantable loop recorder placement, diagnostic cardiac catheterization, and percutaneous coronary intervention (PCI) in a personalized, cost-effective ambulatory setting.
• Clinical Research Studies FDA-regulated investigational medical studies conducted since 1992 and sponsored by pharmaceutical companies, device manufacturers, government, and educational institutions, providing patients access to investigational cardiovascular treatments.
• Electrophysiology Study at Cardiovascular ASC Electrophysiology study service launched at the affiliated Cardiovascular ASC, enabling heart rhythm mapping and identification of abnormal rhythms in an outpatient ambulatory surgery center setting.
• Rhythm Strip Short-duration ECG recording used to assess heart rhythm at a point in time, typically as part of routine cardiac monitoring and follow-up.

Quantifiable outcome

• First electrophysiology study performed at Cardiovascular ASC on May 11, 2026, expanding access to advanced cardiac diagnostic care
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability2 records

Feature6 records

Partnerships

Three partnerships are on record, tiered core.

• Cardiovascular ASC, LLCcoreStrategic or Co-development Partner · 11 May 2026Clearwater Cardiovascular Consultants performs procedures at Cardiovascular ASC, LLC, an affiliated ambulatory surgery center. The first electrophysiology study was performed at this facility on May 11, 2026, expanding patient access to advanced cardiac diagnostic care in a more convenient and cost-effective ambulatory surgery center setting.
• Cardiovascular LogisticscoreStrategic or Co-development Partner · 10 October 2023Clearwater Cardiovascular Consultants announced a partnership with Cardiovascular Logistics (CVL), a physician-owned and physician-led cardiovascular platform. CVL is a national network for board-certified cardiologists focused on expanding practice networks, supporting service growth, and enhancing patient care using advanced technologies and physician autonomy.
• RecoracoreStrategic or Co-development PartnerClearwater Cardiovascular Consultants has partnered with Recora, a leading healthcare technology company, to expand access to virtual cardiac rehabilitation in the Clearwater area. The partnership combines Recora's digital health platform with Clearwater's cardiovascular expertise to provide patients with comprehensive heart health programs, personalized treatment plans, and educational tools for managing heart health from home. Dr. Michael Barry, President and Cardiologist, expressed excitement about providing patients flexibility in participating in cardiac rehab from home.

Scale indicators4 records

Recent moves8 records

Expansion highlights6 records

Others

• Recora: CCC's digital cardiac rehabilitation partner; a virtual cardiac recovery platform serving cardiovascular practices and health systems. Comparable through its direct partnership with CCC rather than as a clinical competitor.
• Cleerly: CCC's AI-powered coronary imaging partner; provides FDA-cleared computer vision software for plaque quantification via CCTA. Adjacent vendor relationship, not a clinical peer, but material to CCC's AI differentiation thesis.

Broad incumbents

• AdventHealth Cardiovascular Institute: Hospital-employed cardiovascular service line operating in the same Tampa Bay / Florida region as CCC. Comparable in subspecialty breadth (interventional, EP, structural heart, imaging) and overlapping patient base, but embedded within a larger health system.
• BayCare Health System (Morton Plant / Mease): CCC's primary hospital partner system in Pinellas County. Operates cardiology, structural heart, and imaging programs that overlap with CCC's service lines; represents both a partner and a potential competitor as systems expand employed-physician models.
• Piedmont Heart Institute: Large integrated cardiovascular service line offering the full spectrum of cardiology, interventional, EP, and structural heart care across multiple sites. Comparable in clinical breadth but operates within a broader health system rather than as an independent group.
• Cleveland Clinic Heart, Vascular & Thoracic Institute: National reference cardiovascular program with deep subspecialty coverage and pioneering structural heart, EP, and imaging capabilities. Sets the clinical benchmark that large community cardiology groups like CCC are measured against.

Direct peers

• Cardiovascular Logistics (CVL): CCC's national platform partner; a physician-owned and physician-led cardiovascular platform building a network of independent cardiology practices with shared infrastructure, contracting, and clinical research. Most direct comparable given formal partnership and identical target practice type.
• US Heart & Vascular: Private-equity-backed cardiovascular care platform partnering with independent cardiology groups across multiple states. Directly comparable consolidation model and target practice profile to CCC's CVL partnership.
• Cardiology Consultants of Philadelphia: Large independent multi-subspecialty cardiology practice with multiple offices, full diagnostic/interventional/electrophysiology services, and an ASC footprint — a structural analog to CCC at greater scale.
• Cardiology Associates of America (CVAUSA): Another physician-led cardiovascular platform consolidating independent cardiology practices nationally. Operates the same playbook as CVL — partnering with large multi-subspecialty cardiology groups, providing infrastructure, and enabling ASC-led outpatient growth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clearwater Cardiovascular Consultants